Carregant...
Complex interactions between the microbiome and cancer immune therapy
Immuno-oncology has rapidly grown in the last thirty years, and immunotherapeutic agents are now approved to treat many disparate cancers. Immune checkpoint inhibitors (ICIs) are employed to augment cytotoxic anti-cancer activity by inhibiting negative regulatory elements of the immune system. Modul...
Guardat en:
| Publicat a: | Crit Rev Clin Lab Sci |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776419/ https://ncbi.nlm.nih.gov/pubmed/31526274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10408363.2019.1660303 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|